APA (7th ed.) Citation

Decroos, A., Cheminant, M., Bruneau, J., Carras, S., Parinet, V., Pelletier, L., . . . Ortonne, N. (2023). KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma. Haematologica (Roma), 108(10), 2830-2836. https://doi.org/10.3324/haematol.2022.282220

Chicago Style (17th ed.) Citation

Decroos, Amandine, et al. "KIR3DL2 May Represent a Novel Therapeutic Target in Aggressive Systemic Peripheral T-cell Lymphoma." Haematologica (Roma) 108, no. 10 (2023): 2830-2836. https://doi.org/10.3324/haematol.2022.282220.

MLA (9th ed.) Citation

Decroos, Amandine, et al. "KIR3DL2 May Represent a Novel Therapeutic Target in Aggressive Systemic Peripheral T-cell Lymphoma." Haematologica (Roma), vol. 108, no. 10, 2023, pp. 2830-2836, https://doi.org/10.3324/haematol.2022.282220.